newsfilter
← Latest News
GlobeNewswire·

Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference

HAYWARD, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ:BNTC) ("Benitec" or the "Company"), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines